Related Experiment Video

Updated: Nov 21, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.1K

Left Ventricular Assist Device Percutaneous Deactivation With a Watchman Device

Tanous Aoun1, Guillaume Baudry2, Gilles Rioufol2

  • 1Department of Cardiac Surgery, Louis Pradel Cardiology Hospital, Lyon, France.

The Annals of Thoracic Surgery
|January 14, 2021
PubMed

Insights

Myocardial recovery is rare in patients with left ventricular assist devices. A Watchman device offers a less invasive percutaneous alternative for HeartMate 3 device deactivation, potentially improving patient outcomes.

Area of Science:

  • Cardiology
  • Medical Devices
  • Interventional Procedures

Background:

  • Myocardial recovery in patients with left ventricular assist devices (LVADs) is infrequent.
  • Surgical explantation of LVADs is associated with significant risks and technical challenges.
  • Percutaneous techniques are emerging as potential alternatives for LVAD deactivation.

Observation:

  • This report details the successful clinical application of a Watchman closure device.
  • The Watchman device was utilized for the deactivation of a HeartMate 3 left ventricular assist device.
  • This represents a novel percutaneous approach to LVAD removal.

Findings:

  • The Watchman closure device facilitated the deactivation of the HeartMate 3 LVAD.
  • This percutaneous method was employed in a clinical setting.
  • The procedure was described in the context of myocardial recovery.

Implications:

  • Percutaneous deactivation using devices like the Watchman may offer a safer alternative to surgical explantation.
  • This technique could expand options for patients experiencing LVAD complications or achieving myocardial recovery.
  • Further research is warranted to evaluate the long-term efficacy and safety of this approach.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.7K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152